healthcare
Bayer buys Legend Capital-backed Dihon Pharma
Bayer has agreed to buy Dihon Pharmaceutical Group, a manufacturer of herbal traditional Chinese medicines (TCM). The acquisition facilitates the exit of Legend Capital, an investor in Dihon since 2010.
EQT buys restructured I-Med from hedge fund owners
Australian radiology provider I-Med Network Radiology is being sold by its hedge fund owners to a consortium led by EQT Partners.
Bamboo Finance, Saama Capital invest in India's Modern Family Doctor
Bamboo Finance, a European private equity firm that focuses on investments benefiting low-income communities in emerging markets, and early stage investor Saama Capital have together taken part in a Series B round of funding for Indian healthcare provider...
CITIC PE considers Biosensors acquisition – update
CITIC Private Equity has held talks about potentially increasing its stake in Singapore-listed portfolio company Biosensors International, the medical device maker said on Wednesday.
CITIC PE to buy medical devices firm Biosensors - report
CITIC Private Equity is said to be looking to buy full control of its Singapore-listed portfolio company Biosensors International, a medical device maker.
TPG, Fosun set for $369m China healthcare take-private
TPG Capital and Fosun Industrial have teamed up with the CEO of Chinese healthcare provider Chindex International have won board approval to privatize the NASDAQ-listed company. The deal values Chindex at approximately $369 million.
JAIC, Nippon Venture lead Series D for Regimmune
Japan Asian Investment Corporation (JAIC) and Nippon Venture Capital have together led a $9.2 million Series D round of investment in Tokyo-based biotech firm Regimmune Corporation.
India impact investments total $390m in 2013 - Unitus
Private equity impact investments in India totaled $390 million across 80 deals last year – comprising 23% of all PE transactions in the country - says Bangalore-based financial advisor Unitus Capital.
Jafco-backed Eleven Bio raises $50m in NASDAQ IPO
Eleven Biotherapeutics, a US biopharma company firm backed by Japan’s Jafco Ventures, has raised $50 million through its NASDAQ IPO – short of the $69 million initially sought.
Portfolio: STIC Investments and Access Bio
STIC Investments backed Access Bio when the Korean-led malaria testing technology player wanted to buy key components and expand output. Now KOSDAQ-listed, the company has its eye on specialty diagnostics
PE-backed Luye, Rundong target HK IPOs – report
Two private equity-backed Chinese companies – Rundong Automobile Group and Luye Pharma Group – are reportedly planning to raise a total of $1.5 billion through Hong Kong listings.
BVCF invests in US-based Jaguar Animal Health
China-focused BVCF has committed $2 million in a Series A round of funding for Jaguar Animal Health, a veterinary drugs developer, with another $3 million to come by the end of the month.
Halifax-backed Envision Pharma acquires Australia's ProScribe
Envision Pharma Group, a scientific communication company backed by US-based private equity firm The Halifax Group, has acquired Australian medical writing firm ProSribe in a move to expand its Asian footprint.
Jungle Ventures backs Singapore's Klinify
Klinify, a Singapore-based electronic medical records management service provider, has received S$770,000 ($604,000) in seed funding round led by Jungle Ventures.
Ventureast leads $3m round in med-tech startup
OneBreath, which makes low-cost portable ventilators, has raised $3 million from the Ventureast Tenet Fund, Villgro, former OnMobile COO Rajiv Kuchhal and BVR Mohan Reddy, founder of Infotech Enterprises, among other investors.
TPG, Carlyle assess exit options for Australia's Healthscope
Healthscope, an Australian hospital operator owned by TPG Capital and The Carlyle Group, looks set for an IPO that could generate proceeds of around A$4 billion ($3.5 billion).
Yunfeng Capital, Alibaba to buy CITIC 21CN for $171m
Yunfeng Capital and Alibaba Group together plan to buy a 54.3% stake in pharmaceutical data provider CITIC 21CN, a Hong Kong-listed subsidiary of Chinese conglomerate CITIC Group, for HK$1.33 billion ($171 million).
Sequoia invests in China Angel Group hospital
Sequoia Capital has invested in a Series B round of funding for Angel Women’s and Children Hospital, a Chengdu-based hospital chain.
Wakabayashi Fund invests in MIT Holding
Wakabayashi Fund, a private equity firm based in Tokyo and New York, has invested in US healthcare firm MIT Holdings. The financial details of the transaction were not disclosed.
Boston Scientific leads round for VC-backed Amaranth Medical
Amaranth Medical, a medical device manufacturer backed by Singapore’s Bio*One Capital and Phillip Private Equity, has received a Series C round of funding from US-listed Boston Scientific.
India Awards: Exit of the Year – Apollo Hospitals
When Apax Partners first invested in Apollo Hospitals Enterprise, in 2007, “healthcare was a relatively undiscovered space for PE in India, even for the public markets for that matter,” says Shashank Singh, who heads the PE firm’s India office.
BVCF supports anti-viral drug innovation
Since the discovery of RNA interference (RNAi), a natural mechanism for regulating gene expression, in the 1990s, billions of dollars have been invested by the world’s pharmaceutical giants in using this technology to develop therapeutic drugs. A particular...
Asian Healthcare Fund leads Series B for Forus Health
Asian Healthcare Fund (AHF) has led a INR500 million ($8 million) Series B round of investment in Forus Health, a Bangalore-based firm that develops affordable medical technology for eye treatment.
BVCF leads $7.5m Series A for Quark Pharma China JV
China-focused life sciences and healthcare investor BVCF has led a RMB45 million ($7.5 million) Series A round of funding for Kunshan RiboQuark Pharmaceutical Technology, a joint venture established by Quark Pharmaceuticals and Suzhou Ribo Life Science.